Licensed for intrathecal use
Products licensed for intrathecal use are the first line option and should be used wherever suitable.
There are currently no known diamorphine products licensed for intrathecal administration.
Not licensed for intrathecal use, limited information available
Products with partial information that are not licensed for intrathecal administration can still sometimes be used. Refer to the advice in our article and complete a risk assessment to enable you to interpret the details below and choose an appropriate product.
Wockhardt
Strength
Excipients
Water for injection (not detectable in the finished product)
Osmolarity / osmolality
Information not available
pH
Information not available
Endotoxin content
≤5.0 IU/mg
Unlicensed ‘Special’, specified for intrathecal use
Unlicensed medicines that are manufactured in MHRA-licensed Specials Manufacturing Units, at the request of an authorised healthcare professional specifically for intrathecal use.
Preston Pharmaceuticals – Royal Preston Hospital
Strength
500 micrograms in 0.5mL PFS
Queen Alexandra Hospital, Portsmouth
Strength
1mg/mL in 1mL PFS
Royal Hospitals, Belfast – Victoria Pharmaceuticals
Strength
500 micrograms/mL in 1mL PFS
Royal Liverpool Hospitals Foundation Trust
Strength
300 micrograms in 0.3mL PFS
500 micrograms in 0.5mL PFS
Stepping Hill Hospital – Stockport Pharmaceuticals
Strength
1mg/mL in 1mL PFS
Update history
- Republished
- Full monograph update
- Title and URL shortened.
- Published